Weiya Ma’s long-term research interest is to advance the understanding of how substances involved in the inflammation process play a role in the development of chronic pain conditions.

Pierre Étienne is a psychiatrist in the geriatric psychiatry program of the Douglas Institute. He is interested in the early development of medication and in Alzheimer's Disease.

Eduardo Chachamovich’s work focuses mainly on social and clinical determinants of mental health in Aboriginal populations.

Marcelo Berlim is mainly interested in the study and treatment of depressive disorders with the use of state-of-the-art neuromodulation techniques.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Patricia Boksa conducts research on pregnancy and birth complications as risk factors for the later development of schizophrenia.

Norbert Schmitz is involved in biostatistics, psychiatric epidemiology and psychometrics.  

Bruno Giros characterizes the neurobiology of schizophrenia and develops improved genetic animal models of this illness.

As a clinician, Johanne Renaud holds the title of medical chief for the youth section of the Douglas Institute’s Depressive Disorders Program.

Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.